财新传媒
财新英文 > 要闻 > 正文

Analysis: China Races to Build Its Own Gene-Editing Toolkit — With an AI Assist

By Zhang Yichuan
2026年08月26日 14:00
To avoid a messy, billion-dollar U.S. patent fight over CRISPR-Cas9, Chinese biotech startups are engineering proprietary DNA scalpels from scratch
Chinese agritech startups are using AI-assisted protein evolution to turn obscure, barely functional enzymes into DNA scalpels.

In a lab in Changzhou, an industrial city in eastern China, researchers at agritech startup Wimi Biotechnology Co. Ltd. are doing something that sounds almost too simple: they “cut” a single stretch of corn DNA, let the plant repair itself, and wait to see what new trait emerges — higher yield, a shorter stalk, less water in the kernel.

  [财新双语通产品,是为有双语需求读者专门订制的优惠产品, 按此可享超值优惠订阅。]

版面编辑:喻竹杨洋
财新网主编精选版电邮 样例
财新网新闻版电邮全新升级!财新网主编精心编写,每个工作日定时投递,篇篇重磅,可信可引。
订阅